China and India Play to Different Strengths

India and China are both rated as low-cost production bases for pharmaceuticals, but some international pharma companies believe the two countries do not compete directly with each other. Hiremath: India far ahead of China Generic drugs manufacturer Actavis (Hafnarfjordur, Iceland) acquired the active pharmaceutical ingredients (API) division of Sanmar Specialty Chemicals (Chennai, India) earlier this year, and has also been expanding in China. Actavis says that each country has an important role to play in the company’s growth. “We believe that costs...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers